The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension
- 1 February 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Quality of Life Research
- Vol. 15 (1), 103-115
- https://doi.org/10.1007/s11136-005-3513-4
Abstract
Objective: No outcome measures specific to pulmonary hypertension (PH) currently exist. The aim of the study was to develop health-related quality of life (symptoms and functioning) scales and a quality of life scale that would allow comprehensive, accurate and valid patient-reported outcome assessment in clinical studies. Methods: The content of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) was derived from qualitative interviews conducted with 35 patients. Item reduction was based on the analysis of responses to a postal survey (n=75) and patient interviews (n=15) designed to determine face and content validity. A final postal validation study (n=91) was performed to determine reproducibility and construct validity. Results: The questionnaire was well received by participants who found it to be relevant, comprehensible and quick and easy to complete. Rasch and factor analyses were conducted to ensure unidimensionality of the final CAMPHOR scales; Overall symptoms (made up of Energy, Breathlessness and Mood subscales), Functioning and Quality of life. The CAMPHOR scales had good internal consistency (α=0.90–0.92) and reproducibility (test–retest correlations=0.86–0.92). They also exhibited convergent, divergent and known groups validity. Conclusions: The CAMPHOR is a valuable new instrument for assessing patient-reported outcome in PH clinical trials and routine practice.Keywords
This publication has 27 references indexed in Scilit:
- Application of Rasch Analysis in the Development and Application of Quality of Life InstrumentsValue in Health, 2004
- The Needs-Based Approach to Quality of Life AssessmentValue in Health, 2004
- Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapyJournal of the American Academy of Dermatology, 2004
- Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritisAnnals Of The Rheumatic Diseases, 2004
- Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trialsBritish Journal of Dermatology, 2003
- Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2003
- Inhaled Iloprost for Severe Pulmonary HypertensionThe New England Journal of Medicine, 2002
- The short form 36 health status questionnaire: clues from the Oxford region's normative data about its usefulness in measuring health gain in population surveys.Journal of Epidemiology and Community Health, 1995
- The QLDS: A scale for the measurement of quality of life in depressionHealth Policy, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990